Skandinaviska Enskilda Banken AB publ Has $12.66 Million Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Skandinaviska Enskilda Banken AB publ lifted its position in Molina Healthcare, Inc. (NYSE:MOH) by 0.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,761 shares of the company’s stock after purchasing an additional 59 shares during the quarter. Skandinaviska Enskilda Banken AB publ owned 0.08% of Molina Healthcare worth $12,664,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Avantax Advisory Services Inc. increased its holdings in Molina Healthcare by 7.6% in the 4th quarter. Avantax Advisory Services Inc. now owns 1,416 shares of the company’s stock valued at $412,000 after buying an additional 100 shares during the period. EverSource Wealth Advisors LLC boosted its position in shares of Molina Healthcare by 81.5% during the 4th quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company’s stock valued at $57,000 after acquiring an additional 88 shares in the last quarter. Sequoia Financial Advisors LLC increased its stake in Molina Healthcare by 28.2% in the fourth quarter. Sequoia Financial Advisors LLC now owns 1,532 shares of the company’s stock valued at $446,000 after acquiring an additional 337 shares during the period. Daiwa Securities Group Inc. raised its position in Molina Healthcare by 25.1% in the fourth quarter. Daiwa Securities Group Inc. now owns 26,307 shares of the company’s stock worth $7,657,000 after purchasing an additional 5,282 shares in the last quarter. Finally, Moran Wealth Management LLC lifted its stake in Molina Healthcare by 1.1% during the fourth quarter. Moran Wealth Management LLC now owns 62,896 shares of the company’s stock worth $18,306,000 after purchasing an additional 675 shares during the period. 98.50% of the stock is owned by institutional investors.

Molina Healthcare Stock Performance

MOH stock opened at $308.51 on Friday. The company has a 50 day moving average price of $297.78 and a 200 day moving average price of $311.20. Molina Healthcare, Inc. has a fifty-two week low of $262.32 and a fifty-two week high of $423.92. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.62 and a quick ratio of 1.62. The stock has a market capitalization of $17.12 billion, a PE ratio of 15.10, a price-to-earnings-growth ratio of 1.06 and a beta of 0.56.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing analysts’ consensus estimates of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. Analysts forecast that Molina Healthcare, Inc. will post 24.4 EPS for the current year.

Insider Buying and Selling at Molina Healthcare

In related news, Director Steven J. Orlando sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total transaction of $301,330.00. Following the completion of the sale, the director now directly owns 17,375 shares of the company’s stock, valued at $5,235,608.75. The trade was a 5.44 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 1.11% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on MOH shares. Truist Financial lowered their price objective on Molina Healthcare from $370.00 to $340.00 and set a “buy” rating on the stock in a research note on Wednesday, February 19th. UBS Group dropped their price objective on Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating for the company in a research note on Friday, February 7th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $350.00 target price (down previously from $378.00) on shares of Molina Healthcare in a research note on Tuesday, December 17th. Barclays lowered their target price on shares of Molina Healthcare from $372.00 to $339.00 and set an “equal weight” rating on the stock in a report on Friday, February 7th. Finally, Wells Fargo & Company raised shares of Molina Healthcare from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $295.00 to $372.00 in a report on Wednesday, March 5th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $355.69.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.